Skip to main content
Log in

T1 mapping in evaluation of clinicopathologic factors for rectal adenocarcinoma

  • Hollow Organ GI
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Objective

T1 mapping has been increasingly applied in the study of tumor. The purpose of this study was to evaluate the value of T1 mapping in evaluating clinicopathologic factors for rectal adenocarcinoma.

Materials and methods

Eighty-six patients with rectal adenocarcinoma confirmed by surgical pathology who underwent preoperative pelvic MRI were retrospectively analyzed. High-resolution T2-weighted imaging (T2WI), T1 mapping, and diffusion-weighted imaging (DWI) were performed. T1 and apparent diffusion coefficient (ADC) parameters were compared among different associated tumor markers, tumor grades, stages, and structure invasion statuses. A receiver operating characteristic (ROC) analysis was estimated.

Results

T1 value showed significant difference between high- and low-grade tumors ([1531.5 ± 84.7 ms] vs. [1437.1 ± 80.3 ms], < 0.001). T1 value was significant higher in positive than in negative perineural invasion ([1495.7 ± 89.2 ms] vs. [1449.4 ± 88.8 ms], < 0.05). No significant difference of T1 or ADC was observed in different CEA, CA199, T stage, N stage, lymphovascular invasions, extramural vascular invasion (EMVI), and circumferential resection margin (CRM) (> 0.05). The AUC under ROC curve of T1 value were 0.796 in distinguishing high- from low-grade rectal adenocarcinoma. The AUC of T1 value in distinguishing perineural invasion was 0.637.

Conclusion

T1 value was helpful in assessing pathologic grade and perineural invasion correlated with rectal cancer.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article. The datasets are available from the corresponding author on reasonable request.

Abbreviations

ADC:

Apparent diffusion coefficient

AUC:

Area under the curve

AJCC:

American Joint Committee on Cancer

CRM:

Circumferential resection margin

CI:

Confidence interval

DWI:

Diffusion-weighted imaging

EMVI:

Extramural vascular invasion

MRI:

Magnetic resonance imaging

ROC:

Receiver operating characteristic

ROI:

Region of interest

ss-EPI:

Single-shot echo plane imaging

TNM:

Tumor-node-metastasis

T2W:

T2 weighted

TSE:

Turbo spin echo

TA:

Acquisition time

TE:

Echo time

TR:

Repetition time

WHO:

World Health Organization

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.

    Article  PubMed  Google Scholar 

  2. Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Clin Gastroenterol Hepatol. 2021;19(5):955-966.e61.

    Article  PubMed  Google Scholar 

  3. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29:263.

    Article  Google Scholar 

  4. Wilkinson N. Management of Rectal Cancer. Surg Clin North Am. 2020;100(3):615-628.

    Article  PubMed  Google Scholar 

  5. Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim DH. Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol (NY). 2019;44(11):3536-3548.

    Article  PubMed  Google Scholar 

  6. Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367-387.

  7. Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhu L, Pan Z, Ma Q, Yang W, Shi H, Fu C, et al. Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: preliminary findings. Radiology. 2017;284(1):66-76.

    Article  PubMed  Google Scholar 

  9. Yamada I, Yoshino N, Hikishima K, Miyasaka N, Yamauchi S, Uetake H, et al. Colorectal carcinoma: Ex vivo evaluation using 3-T high-spatial-resolution quantitative T2 mapping and its correlation with histopathologic findings. Magn Reson Imaging. 2017; 38:174-181.

    Article  PubMed  Google Scholar 

  10. Ma L, Lian S, Liu H, Meng T, Zeng W, Zhong R, et al. Diagnostic performance of synthetic magnetic resonance imaging in the prognostic evaluation of rectal cancer. Quant Imaging Med Surg. 2022;12(7):3580-3591.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016;9(1):67-81.

    Article  PubMed  Google Scholar 

  12. Gao Y, Wang HP, Liu MX, Liu MX, Gu H, Yuan XS, et al. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis. Eur Radiol. 2022;33:1982-1991.

    Article  PubMed  Google Scholar 

  13. Liu M, Shao L, Yang Z, Wang Q, Wu B, Liu X, et al. Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma. J Immunol Res. 2022; 2022:3094933.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wu J, Shi Z, Zhang Y, Yan J, Shang F, Wang Y, et al. Native T1 Mapping in Assessing Kidney Fibrosis for Patients with Chronic Glomerulonephritis. Front Med (Lausanne). 2021; 8:772326.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Von Ulmenstein S, Bogdanovic S, Honcharova-Biletska H, Blümel S, Deibel AR, Segna D, et al. Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard. Abdom Radiol (NY). 2022;47(11):3746-3757.

    Article  Google Scholar 

  16. Li J, Cao B, Bi X, Chen W, Wang L, Du Z, et al. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study. Radiol Med. 2021; 126(9):1149-1158.

    Article  PubMed  Google Scholar 

  17. Liu Z, Yang S, Chen X, Luo C, Feng J, Chen H, et al. Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping. Front Oncol. 2022; 12:954445.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Wang S, Li J, Zhu D, Hua T, Zhao B. Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in identifying clear cell renal cell carcinoma histopathological grade and differentiating fat-poor angiomyolipoma. Quant Imaging Med Surg. 2020;10(5):988-998.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Li J, Gao X, Dominik Nickel M, Cheng J, Zhu J. Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study. Cancer Imaging. 2022;22(1):30.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gilligan LA, Dillman JR, Tkach JA, Xanthakos SA, Gill JK, Trout AT. Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla. Pediatric Radiology. 2019;49(8):1018-1024.

    Article  PubMed  Google Scholar 

  21. Inoue A, Sheedy SP, Heiken JP, Mohammadinejad P, Graham RP, Lee HE, et al. MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy. Insights Imaging. 2021;12(1):110.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, et al. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677-685.

    Article  PubMed  Google Scholar 

  23. Meng T, He N, He H, Liu K, Ke L, Liu H, et al. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI. Cancer Imaging. 2020;20(1):88.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Adams LC, Jurmeister P, Ralla B, Bressem KK, Fahlenkamp UL, Engel G, et al. Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings. Eur Radiol. 2019;29(11):5832-5843

    Article  PubMed  Google Scholar 

  25. Qin X, Yang T, Huang Z, Long L, Zhou Z, Li W, et al. Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. Oncol Lett. 2019;18(3):2322-2329.

    PubMed  PubMed Central  CAS  Google Scholar 

  26. Li J, Lin L, Gao X, Li S, Cheng J. Amide Proton Transfer Weighted and Intravoxel Incoherent Motion Imaging in Evaluation of Prognostic Factors for Rectal Adenocarcinoma. Front Oncol. 2022; 11:783544.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Yuan Y, Pu H, Chen GW, Chen XL, Liu YS, Liu H, et al. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer. Eur Radiol. 2021;31(1):200-211.

    Article  PubMed  Google Scholar 

  28. Ge YX, Hu SD, Wang Z, Guan RP, Zhou XY, Gao QZ, et al. Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer. Eur Radiol. 2021;31(5):3347-3354.

    Article  PubMed  Google Scholar 

  29. Mc Entee PD, Shokuhi P, Rogers AC, Mehigan BJ, McCormick PH, Gillham CM, et al. Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death. Eur J Surg Oncol. 2022;48(7):1638-1642.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge all the colleagues and participants in this hospital for their supports, especially the Department of MRI, the First Affiliated Hospital of Zhengzhou University.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

JL, YX, and HJ made contribution to collecting patients. JL, LL, and PK made data analysis and interpretation. JL, PK, YZ, and JC were major contributors. All authors made a substantial contribution to researching data, discussion of content, and reviewing and editing manuscript before submission. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Juan Li.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethical approval

This study was approved by our institutional ethics committee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Kou, P., Lin, L. et al. T1 mapping in evaluation of clinicopathologic factors for rectal adenocarcinoma. Abdom Radiol 49, 279–287 (2024). https://doi.org/10.1007/s00261-023-04045-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-023-04045-2

Keywords

Navigation